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Catalytic Reduction of Alkyl and Aryl Bromides using Isopropanol  
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Abstract: Milstein’s complex (PNN)RuHCl(CO) catalyzes the efficient reduction of aryl and alkyl halides under relatively mild conditions, 
using isopropanol and a base. Sterically hindered tertiary and neopentyl substrates are reduced efficiently, as well as more functionalized aryl 
and alkyl bromides. The reduction process is proposed to occur via radical abstraction/hydrodehalogenation steps at ruthenium. Our research 
represents a safer and more sustainable alternative to typical silane, lithium aluminium hydride, and tin-based conditions for these reductions. 
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1. Additional Optimization Information 
 
Figure S1. Comparison of the reaction kinetics for 1b and 2c 
 
Given that 2c resulted in ca. 30% higher conversion than the next best catalyst during optimization, 1b, we compared the kinetic 
profiles of these two species. Under the optimized reaction conditions (1.00 mmol scale, 1.2 equiv NaOt-Bu, 1 mol % cat., 0.2 M i-
PrOH), we monitored the reaction of 3a with both 2c and 1b over time as shown in Figure 2. The reaction using 2c is initially faster, 
and reaches a maximum conversion of 96% in ≤40 minutes at 100°C. The reaction using 1b requires ~90 min to reach a maximum 
conversion of 70%. Hence the iridium complex 1b is both initially slower and more readily deactivated than the ruthenium complex 2c.  
 
 
 
Figure S2. Results using Cs2CO3 as a base. 
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2. Experimental Procedures 
General Information: All manipulations of metal complexes were carried out under atmospheres of N2 or argon using standard 
airfree techniques. 1H, 13C and 31P NMR were recorded on Varian and Bruker 300 and 400 MHz spectrometers. 1H and 13C NMR are 
reported in ppm (δ) and referenced[1] to residual solvents. 31P NMR are referenced to 85% H3PO4 (0.00 ppm). GC analyses were 
conducted on an Agilent 6800 instrument with an Agilent HP-5 column.  Column chromatography was carried out using silica gel F60, 
230-400 mesh from Silicycle. CAM (cerium ammonium molbydate) and PMA (phosphomolybdic acid) stains were prepared according 
to Not Voodoo.[2] Isopropanol (anhydrous) was purchased from Sigma-Aldrich and sparged with argon before use. Iridium complexes 
1a-e were prepared according to the literature.[3] Ruthenium complexes 2a-c were purchased from Sigma-Aldrich. Commercially 
available halide substrates were purchased in the highest available purity and used as received. Older substrates from existing 
chemical stock were purified by filtration through a plug of neutral alumina before use. 
General procedure for reduction with 2c: Inside a N2 glovebox, a 20 mL septum-capped vial was charged with 1.00 mmol 
organohalide (if solid), 115 mg NaOt-Bu (1.20 mmol) and 4.4 mg 2c (0.01 mmol, 1 mol%). The vial was capped and removed from 
the glovebox. 5.0 mL anhydrous degassed i-PrOH was then added via syringe, followed by 1.00 mmol organohalide (if liquid). The 
vial was then stirred at 100 °C on a hotplate using an aluminum block, with the solvent level remaining above the top of the well. The 
reaction was monitored by GC or TLC. 
Workup procedure A: After completion, the vial was cooled to room temperature and the reaction mixture diluted with pentane. 
The mixture was washed with H2O and brine. The combined aqueous layers were extracted with pentane. The organic layers were 
dried over Na2SO4 and purified by column chromatography (SiO2, pentane). 
Workup procedure B: After completion, the vial was cooled to room temperature and the reaction mixture was concentrated in 
vacuo. The resulting crude product was dissolved in EtOAc and washed with H2O and brine. The organic layer was dried over MgSO4, 
concentrated in vacuo and purified by column chromatography (SiO2). 
3. Characterization of Products 
n-Decane: Isolated as a colorless oil (134 mg, 0.93 mmol, 93% yield) from 1-bromodecane following the general procedure and 
workup procedure A. Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 1.47 – 1.16 (m, 16H), 0.92 (t, J = 6.8 
Hz, 6H). 13C NMR (101 MHz, Chloroform-d) δ 31.97, 29.71, 29.41, 22.72, 14.10.[4] 
1-Ethyl-4-methoxybenzene: Isolated as a colorless oil (129 mg, 0.95 mmol, 95% yield) from 1-(2-chloroethyl)-4-
methoxybenzene following the general procedure and workup procedure A. Spectral data matched the literature: 1H NMR (400 MHz, 
Chloroform-d) δ 7.17 (d, J = 8.7 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 3.83 (s, 3H), 2.86 – 2.49 (m, 2H), 1.28 (t, J = 7.6 Hz, 3H). 13C NMR 
(101 MHz, Chloroform-d) δ 157.67, 136.38, 128.71, 113.75, 55.20, 28.02, 15.93.[5] 
Adamantane: Isolated as a colorless solid (128 mg, 0.94 mmol, 94% yield) from 1-bromoadamantane following the general 
procedure and workup procedure A. Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 1.87 (s, 3H), 1.75 (t, J 
= 3.2 Hz, 9H). 13C NMR (101 MHz, Chloroform-d) δ 37.90, 28.48. mp 192-195°C (sublimed)[6] 
Adamantane: Isolated as a colorless solid (131 mg, 0.95 mmol, 95% yield) from 2-bromoadamantane following the general 
procedure and workup procedure A. Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 1.87 (s, 3H), 1.75 (t, J 
= 3.2 Hz, 9H). 13C NMR (101 MHz, Chloroform-d) δ 37.90, 28.48. 
n-Propoxybenzene: Isolated as a colorless oil (120 mg, 0.88 mmol, 88% yield) from (3-bromopropoxy)benzene following the 
general procedure and workup procedure A. Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 7.45 – 7.18 (m, 
2H), 7.05 – 6.82 (m, 3H), 3.97 (t, J = 6.6 Hz, 2H), 1.87 (dtd, J = 13.9, 7.4, 6.5 Hz, 2H), 1.10 (t, J = 7.4 Hz, 3H). 13C NMR (101 MHz, 
Chloroform-d) δ 159.14, 129.44, 120.48, 114.51, 69.38, 22.66, 10.59.[7] 
Naphthalene: Isolated as a colorless solid (122 mg, 0.95 mmol, 95% yield) from 1-bromonaphthalene following the general 
procedure and workup procedure A. Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 7.88 (dq, J = 6.2, 2.8 
Hz, 4H), 7.52 (dt, J = 6.3, 3.1 Hz, 4H). 13C NMR (101 MHz, Chloroform-d) δ 133.46, 127.90, 125.83. mp 72-76 °C[8] 
Isopropyl benzoate: Isolated as a colorless oil (148 mg, 0.90 mmol, 90% yield) from methyl 4-bromobenzoate and workup 
procedure B. Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 8.09 – 7.99 (m, 2H), 7.63 – 7.51 (m, 1H), 7.51 
– 7.35 (m, 2H), 5.26 (hept, J = 6.3 Hz, 1H), 1.37 (d, J = 6.3 Hz, 6H). 13C NMR (101 MHz, Chloroform-d) δ 166.13, 132.69, 130.90, 
129.50, 128.26, 68.35, 21.97.[9] 
1,3-Bis(trifluoromethyl)benzene: Isolated as a colorless oil (158 mg, 0.74 mmol, 74% yield) from 1,3-bis(trifluoromethyl)-5-
bromobenzene following the general procedure and workup procedure A. Volatile product. Spectral data matched the literature: 1H 
NMR (400 MHz, Chloroform-d) δ 7.89 (s, 1H), 7.82 (d, J = 8.1 Hz, 2H), 7.64 (t, J = 7.9 Hz, 1H). 19F NMR (376 MHz, Chloroform-d) δ -
63.17.[10] 
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Mesitylene: Isolated as a colorless oil (107 mg, 0.89 mmol, 89% yield) from 2-bromomesitylene following the general procedure 
with 2 mol% 2c, and 48 h reaction time. Workup procedure A was used. Spectral data matched the literature: 1H NMR (500 MHz, 
Chloroform-d) δ 6.86 (s, 1H), 2.34 (s, 3H).[1] 
1,1-dimethylcyclohexane: Isolated as a colorless oil (78 mg, 0.70 mmol, 70% yield) from 3h following the general procedure and 
workup procedure A. Volatile product. Spectral data matched the literature: 1H NMR (500 MHz, Chloroform-d) δ 1.47 – 1.40 (m, 5H), 
1.24 (dt, J = 11.2, 6.1 Hz, 5H), 1.14 (s, 2H), 0.83 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 37.94, 32.22, 26.64, 22.13.[11] 
Benzyl (S)-2-methylpyrrolidine-1-carboxylate: Inside an N2 glovebox, a 20 mL septum-capped vial was charged with 115 mg 
NaOt-Bu (1.20 mmol) and 4.4 mg 2c (0.01 mmol, 1 mol%). The vial was capped and removed from the glovebox. 5.0 mL anhydrous 
degassed i-PrOH was then added via syringe, followed by 298 mg 3n (1.00 mmol). The reaction was stirred at room temperature. 
After 24 h, the reaction appeared complete by TLC (DCM, CAM stain). The reaction mixture was extracted with ether, washed with 
water, brine and dried over MgSO4. The crude product was purified by column chromatography (SiO2, DCM) to afford the title 
compound as a colorless oil (187 mg, 0.85 mmol, 85% yield). Spectral data matched the literature:  1H NMR (500 MHz, Chloroform-d) 
δ 7.42 – 7.20 (m, 5H), 5.14 (p, J = 12.0 Hz, 2H), 3.99 (s, 1H), 3.44 (s, 2H), 2.04 – 1.74 (m, 3H), 1.58 (s, 1H), 1.16 (s, 3H). 13C NMR 
(126 MHz, Chloroform-d), observed as two rotamers, δ 128.40, 127.78, 66.58, 66.34, 53.43, 52.84, 46.63, 46.25, 33.25, 23.65, 22.91, 
20.86, 20.00.[12] Enantiomeric excess was determined to be >99% by SFC (AD-H, 2% i-PrOH, 3.0 mL/min), using a racemic sample 
prepared by the reaction of rac-2-methylpyrrolidine with Cbz-Cl and i-Pr2NEt in DCM. 
Hexahydro-2H-3,5-methanocyclopenta[b]furan-2-one: Isolated as a colorless solid (99 mg, 0.72 mmol, 72% yield) from 
bromolactone 3r following the general procedure, using 1.0 equiv NaOt-Bu at room temperature. Workup procedure B was used. 
Column condition: 50% hexanes/DCM. Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 4.76 (dd, J = 5.0, 
7.9 Hz, 1H), 3.17 (tq, J = 4.9, 1.5 Hz, 1H), 2.51 (ddt, J = 11.3, 4.9, 1.5 Hz, 1H), 2.43 (ddp, J = 3.8, 2.9, 0.9 Hz, 1H), 1.94 (ddt, J = 13.0, 
11.3, 3.4 Hz, 1H), 1.80 – 1.66 (m, 3H), 1.62 – 1.54 (m, 2H), 1.50 (ddd, J = 14.1, 2.3, 0.9 Hz, 1H). 13C NMR (101 MHz, Chloroform-d) 
δ 181.58, 80.93, 46.50, 39.14, 38.16, 37.94, 36.52, 34.52. 
4. Preparation of unreported compound 1-bromomethyl-1-methylcyclohexane 
1-hydroxymethyl-1-methylcyclohexane: A solution of 2.84 g (20.0 mmol) 1-methylcyclohexane carboxylic acid in THF (40 mL, 
0.2 M) was cooled with an ice-water bath and 3.8 mL (40 mmol) BH3-DMS complex was added dropwise (gas evolves). The ice-water 
bath was removed and the reaction was stirred for 48 h at room temperature, then cooled again with an ice-water bath. H2O was 
added carefully until no more gas evolved, then the mixture was extracted with 3 x 25 mL DCM. The DCM layers were washed with 
aq. NaHCO3 and dried over MgSO4. Concentration in vacuo afforded the title compound as a clear colorless oil: 2.40 g (18.8 mmol, 
94% yield). Spectral data matched the literature: 1H NMR (400 MHz, Chloroform-d) δ 3.73 (s, 1H), 3.32 (s, 2H), 1.84 (s, 1H), 1.74 – 
1.10 (m, 11H), 0.89 (s, 3H).13 
1-bromomethyl-1-methylcyclohexane: A stirred solution of 614 mg (5.00 mmol) 1-hydroxymethyl-methylcyclohexane and 1.44 
g (5.50 mmol) PPh3 in 5.0 mL (1.0 M) DMF was cooled in a water bath under argon. Br2 was added dropwise until an orange color 
persisted (ca. 0.13 mL). The reaction mixture was then heated to 150°C for 30 min, and cooled to room temperature. The resulting 
dark solution was diluted with 25 mL water and 25 mL pentane, stirred and filtered. The mixture was separated and extracted with 2 x 
10 mL pentane. The pentane extracts were washed with 2 x 25 mL brine, then dried (Na2SO4) and filtered through a plug of SiO2. 
Concentration afforded the title product as a clear colorless oil: 279 mg (1.46 mmol, 29% yield). This compound was previously 
reported in the literature but not fully characterized.14 1H NMR (500 MHz, Chloroform-d) δ 3.34 (s, 2H), 1.52 – 1.42 (m, 5H), 1.42 – 
1.35 (m, 4H), 1.35 – 1.28 (m, 1H), 1.00 (s, 3H). 13C NMR (126 MHz, Chloroform-d) δ 47.62, 35.89, 34.27, 26.10, 22.02. HRMS (EI+) 
for C8H15Br: calculated 190.0357, measured 190.0358. 
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